Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Glucose | 9 | 2024 | 486 | 1.450 |
Why?
|
| Hypoglycemic Agents | 4 | 2019 | 221 | 1.150 |
Why?
|
| Diabetes Mellitus | 5 | 2016 | 541 | 1.130 |
Why?
|
| Insulin | 6 | 2019 | 684 | 1.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 708 | 0.890 |
Why?
|
| Obesity | 4 | 2015 | 1247 | 0.770 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2019 | 629 | 0.690 |
Why?
|
| Hypoglycemia | 3 | 2019 | 65 | 0.670 |
Why?
|
| Endocrinologists | 1 | 2016 | 5 | 0.510 |
Why?
|
| Physician's Role | 1 | 2016 | 124 | 0.460 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 32 | 0.450 |
Why?
|
| Bariatric Surgery | 2 | 2015 | 62 | 0.450 |
Why?
|
| Gastric Bypass | 2 | 2015 | 69 | 0.430 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 158 | 0.410 |
Why?
|
| Adipocytes | 2 | 2015 | 269 | 0.400 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 113 | 0.400 |
Why?
|
| Motor Activity | 1 | 2015 | 346 | 0.370 |
Why?
|
| Energy Metabolism | 1 | 2015 | 384 | 0.370 |
Why?
|
| Point-of-Care Systems | 1 | 2013 | 132 | 0.350 |
Why?
|
| Prediabetic State | 1 | 2012 | 53 | 0.350 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2024 | 62 | 0.340 |
Why?
|
| Radiation Oncology | 1 | 2024 | 52 | 0.210 |
Why?
|
| Self-Management | 1 | 2024 | 64 | 0.200 |
Why?
|
| Humans | 19 | 2024 | 64252 | 0.200 |
Why?
|
| Weight Loss | 3 | 2015 | 273 | 0.190 |
Why?
|
| Glucose Tolerance Test | 3 | 2012 | 97 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2024 | 575 | 0.190 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 478 | 0.170 |
Why?
|
| Adipose Tissue | 2 | 2014 | 296 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 1683 | 0.150 |
Why?
|
| Patient Satisfaction | 2 | 2024 | 438 | 0.140 |
Why?
|
| Unified Medical Language System | 1 | 2018 | 6 | 0.140 |
Why?
|
| PubMed | 1 | 2018 | 9 | 0.140 |
Why?
|
| Remission Induction | 2 | 2015 | 147 | 0.140 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 24 | 0.130 |
Why?
|
| Risk Factors | 3 | 2017 | 5339 | 0.130 |
Why?
|
| Milk Proteins | 1 | 1997 | 45 | 0.130 |
Why?
|
| Caseins | 1 | 1997 | 42 | 0.130 |
Why?
|
| Milk | 1 | 1997 | 45 | 0.130 |
Why?
|
| Pancreas, Artificial | 1 | 2016 | 2 | 0.130 |
Why?
|
| Insulin Infusion Systems | 1 | 2016 | 11 | 0.130 |
Why?
|
| Glucagon | 1 | 2016 | 33 | 0.130 |
Why?
|
| Physician Assistants | 1 | 2016 | 36 | 0.130 |
Why?
|
| Hormones | 1 | 2016 | 60 | 0.130 |
Why?
|
| Male | 9 | 2024 | 30305 | 0.120 |
Why?
|
| Pregnancy | 2 | 2015 | 2370 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1997 | 201 | 0.120 |
Why?
|
| Nurse Practitioners | 1 | 2016 | 117 | 0.120 |
Why?
|
| Female | 9 | 2024 | 33360 | 0.120 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 10 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2018 | 368 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2014 | 5 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2015 | 5691 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 260 | 0.100 |
Why?
|
| Neoplasms | 1 | 2024 | 1392 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2015 | 199 | 0.100 |
Why?
|
| Diet | 1 | 1997 | 533 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 93 | 0.100 |
Why?
|
| Laboratories | 1 | 2013 | 27 | 0.100 |
Why?
|
| Calibration | 1 | 2013 | 67 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 230 | 0.100 |
Why?
|
| Bias | 1 | 2013 | 114 | 0.100 |
Why?
|
| Capillaries | 1 | 2012 | 31 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 50 | 0.090 |
Why?
|
| Ergolines | 1 | 2012 | 1 | 0.090 |
Why?
|
| Prolactinoma | 1 | 2012 | 4 | 0.090 |
Why?
|
| Coronary Aneurysm | 1 | 2012 | 7 | 0.090 |
Why?
|
| Pituitary Neoplasms | 1 | 2012 | 21 | 0.090 |
Why?
|
| Coronary Vasospasm | 1 | 2012 | 11 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 104 | 0.090 |
Why?
|
| Comorbidity | 1 | 2015 | 1118 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 36 | 0.090 |
Why?
|
| Adult | 6 | 2024 | 17121 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 158 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2015 | 872 | 0.090 |
Why?
|
| Middle Aged | 6 | 2024 | 17906 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2012 | 140 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2016 | 711 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2011 | 106 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 1162 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1001 | 0.080 |
Why?
|
| Diabetes, Gestational | 1 | 2012 | 142 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 189 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2017 | 6732 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2011 | 409 | 0.070 |
Why?
|
| Biomarkers | 2 | 2011 | 1431 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5527 | 0.070 |
Why?
|
| Self Efficacy | 1 | 2024 | 203 | 0.050 |
Why?
|
| Text Messaging | 1 | 2024 | 86 | 0.050 |
Why?
|
| Rats, Inbred BB | 3 | 1997 | 134 | 0.050 |
Why?
|
| Self Care | 1 | 2024 | 214 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2003 | 105 | 0.050 |
Why?
|
| Aged | 1 | 2017 | 14657 | 0.040 |
Why?
|
| Health Behavior | 1 | 2024 | 474 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1019 | 0.040 |
Why?
|
| Inpatients | 1 | 2003 | 303 | 0.040 |
Why?
|
| Rats | 3 | 1997 | 2005 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2018 | 47 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1997 | 46 | 0.030 |
Why?
|
| Bionics | 1 | 2016 | 3 | 0.030 |
Why?
|
| ADP Ribose Transferases | 1 | 1997 | 63 | 0.030 |
Why?
|
| Cattle | 1 | 1997 | 316 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 163 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 111 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 163 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 1996 | 127 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 1996 | 82 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 4780 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 1996 | 280 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 85 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 1996 | 576 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1997 | 671 | 0.030 |
Why?
|
| Incidence | 1 | 1997 | 1383 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 490 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2014 | 175 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 1997 | 2238 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 176 | 0.020 |
Why?
|
| Adiponectin | 1 | 2012 | 37 | 0.020 |
Why?
|
| Physicians | 1 | 2018 | 483 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2012 | 77 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2012 | 38 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1997 | 1019 | 0.020 |
Why?
|
| Animals | 4 | 2014 | 20961 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 104 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 209 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 448 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1769 | 0.020 |
Why?
|
| Aging | 1 | 1996 | 754 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 650 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2480 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1103 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3450 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 3724 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 3070 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2003 | 56 | 0.010 |
Why?
|
| Connecticut | 1 | 2003 | 87 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 66 | 0.010 |
Why?
|
| Hospitals, Community | 1 | 2003 | 71 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 6304 | 0.010 |
Why?
|
| Patient Selection | 1 | 2003 | 487 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 11003 | 0.010 |
Why?
|
| Isoantigens | 1 | 1997 | 72 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 1997 | 40 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1997 | 109 | 0.010 |
Why?
|
| Thyroiditis | 1 | 1996 | 11 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1996 | 165 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1996 | 247 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 1332 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 761 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 1997 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1996 | 1551 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1996 | 1621 | 0.000 |
Why?
|